It's late on Friday as tired bankers and lawyers put the final touches to an IPO. Finally the senior...
It's late on Friday as tired bankers and lawyers put the final touches to an IPO. Finally the senior banker walks nervously to a room occupied by young men and women with purple hair and dogs on pieces of string à the bank's standing committee of animal rights activists. He lays the IPO proposal before them. "Is this one okay?" he asks timidly. Far-fetched? Not judging by what's happened to a company called Huntingdon Life Sciences Group, the pharmaceuticals testing business. In the history of the City of London, few more shameful chapters have been written. Huntingdon tests new dru...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes